NOCIL Limited (NSE:NOCIL)
142.30
-1.51 (-1.05%)
Nov 12, 2026, 3:29 PM IST
NOCIL Revenue
NOCIL had revenue of 4.27B INR in the quarter ending September 30, 2026, with 33.17% growth. This brings the company's total for the last twelve months to 14.76B, up 12.29% year-over-year. In the fiscal year ending March 31, 2026, NOCIL had annual revenue of 13.03B, down -6.44%. That makes NOCIL the 19,225th largest company in the world by revenue and 1,080th in India.
Revenue (ttm)
14.76B
Revenue Growth
+12.29%
P/S Ratio
1.62
Revenue / Employee
19.20M
Employees
769
Market Cap
23.77B
Revenue by Geography
- India 8.63B 66.2%
- Outside India 4.40B 33.8%
Fiscal year ended Mar 31, 2026 See the full NOCIL breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 13.03B | -897.20M | -6.44% |
| Mar 31, 2025 | 13.93B | -519.80M | -3.60% |
| Mar 31, 2024 | 14.45B | -1.72B | -10.63% |
| Mar 31, 2023 | 16.17B | 452.60M | 2.88% |
| Mar 31, 2022 | 15.71B | 6.47B | 69.93% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossari Biotech | 26.61B |
| S H Kelkar and Company | 25.31B |
| Veedol Corporation | 24.01B |
| Jubilant Agri and Consumer Products | 20.52B |
| Indigo Paints | 15.13B |
| Shree Pushkar Chemicals & Fertilisers | 11.52B |
| Advanced Enzyme Technologies | 7.82B |
| Tatva Chintan Pharma Chem | 6.50B |
NOCIL News
- 13 days ago - NOCIL Transcript: Q2 26/27 - Transcripts
- 13 days ago - NOCIL Quarterly report: Q2 2027 - Filings
- 13 days ago - NOCIL Slides: Q2 2027 - Filings
- 3 months ago - NOCIL Transcript: Q1 26/27 - Transcripts
- 3 months ago - NOCIL Quarterly report: Q1 2027 - Filings
- 3 months ago - NOCIL Slides: Q1 2027 - Filings
- 6 months ago - NOCIL Transcript: Q4 25/26 - Transcripts
- 6 months ago - NOCIL Annual report: Q4 2026 - Filings